COVID-19: Caring for Patients and Communities
The AHA and its members are partnering with the Department of Health and Human Services to encourage eligible patients who recover from COVID-19 to donate convalescent plasma, which contains antibodies that could help other patients fight the virus.
Congress returns to Washington, D.C., on Monday, and the stakes are extremely high. The Senate will begin serious negotiations on the next COVID-19 relief package, and we expect Congress to pass legislation before the August congressional recess.
Americans overwhelmingly support hospitals and further aid as front-line health care providers fight to defeat COVID-19, regardless of party affiliation, according to a poll released by the Coalition to Protect America’s Health Care.
A new AHA podcast explores how rural hospitals have found new ways to deliver care to patients with COVID-19.
Wear a mask. Wash your hands. Keep your distance. These are three simple actions we know that will stop the spread of COVID-19. The AHA, American Medical Association and the American Nurses Association shared those messages in an open letter to the American public.
.webreplay{
border: solid 2px #777;
padding: 15px 5px;
margin: 0 0 10px 15px;
}
@media (min-width:360px){
.webreplay{
min-width: 290px;
float: right;
}
}
On-demand Webinar
MktoForms2.loadForm("//app-sj20.marketo.com", "734-ZTO-041", 5819);
Rogers Behavioral Health…
The Department of Veterans Affairs July 8 will host a webinar featuring clinicians who will present a case-based educational session on performing cognitive evaluations for veterans with dementia warning signs when face-to-face care is not possible due to COVID-19.
The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer questions about the COVID-19 pandemic.
A recent article in the Wall Street Journal about coronavirus infections in hospitals speaks to the spread of this disease and the importance of taking the utmost precautions – everywhere and at all times.
The Department of Health and Human Services and Department of Defense announced a $1.6 billion agreement to demonstrate commercial-scale manufacturing of Novavax, Inc.’s investigational COVID-19 vaccine.